Literature DB >> 2924453

Loss of spontaneous metastasizing potential in mouse mammary tumors.

J Vaage1.   

Abstract

Among 25 C3H/He and C3Hf/He spontaneous mammary tumors that all had produced pulmonary metastases in the autochthonous mice, and also produced pulmonary metastases during subsequent sequential syngeneic intramammary passages, three were observed to stop producing metastases. The specific investigation of the observed changes in behavior is described. When the tumors were re-started in serial intramammary passage from early, cryopreserved transplant generations, the loss of metastasizing potential reoccurred in the same, or in nearly the same, transplant generations. In one tumor from which three transplant lines had been established, the metastasizing potential was lost in all transplant lines during closely related transplant generations. It seems that a spontaneous reduction of malignant behavior in mouse mammary tumors may be an occasional neoplastic characteristic, and that the observed losses of metastasizing potential may have been determined by a programmed genetic change.

Entities:  

Mesh:

Year:  1989        PMID: 2924453     DOI: 10.1007/BF01753688

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  17 in total

1.  Increased tumor metastasis after in vitro alteration of the cell surface.

Authors:  R C Parks
Journal:  J Natl Cancer Inst       Date:  1975-06       Impact factor: 13.506

2.  Induction of thymidine kinase in enzyme-deficient Chinese hamster cells.

Authors:  M Harris
Journal:  Cell       Date:  1982-06       Impact factor: 41.582

3.  Changes in malignant phenotype of a human carcinoma conditioned by growth environment.

Authors:  L Ossowski; E Reich
Journal:  Cell       Date:  1983-06       Impact factor: 41.582

4.  A survey of the growth characteristics of and the host reactions to one hundred C3H/He mammary carcinomas.

Authors:  J Vaage
Journal:  Cancer Res       Date:  1978-02       Impact factor: 12.701

5.  Clonal drift of cell surface, melanogenic, and experimental metastatic properties of in vivo-selected, brain meninges-colonizing murine B16 melanoma.

Authors:  K M Miner; T Kawaguchi; G W Uba; G L Nicolson
Journal:  Cancer Res       Date:  1982-11       Impact factor: 12.701

6.  Metastasizing potentials of mouse mammary tumors and their metastases.

Authors:  J Vaage
Journal:  Int J Cancer       Date:  1988-06-15       Impact factor: 7.396

7.  Inherent changes in the in vivo growth characteristics of C3H/He mammary carcinomas.

Authors:  J Vaage
Journal:  Cancer Res       Date:  1980-10       Impact factor: 12.701

8.  Increasing metastatic potential is associated with increasing genetic instability of clones isolated from murine neoplasms.

Authors:  M A Cifone; I J Fidler
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

9.  Phenotypic drift of metastatic and cell-surface properties of mammary adenocarcinoma cell clones during growth in vitro.

Authors:  A Neri; G L Nicolson
Journal:  Int J Cancer       Date:  1981-12       Impact factor: 7.396

10.  The effect of passage in vitro and in vivo on the properties of murine fibrosarcomas I. Tumorigenicity and immunogenicity.

Authors:  M F Woodruff; B A Hodson
Journal:  Br J Cancer       Date:  1985-02       Impact factor: 7.640

View more
  3 in total

1.  The use of quantitative genetics for estimating the non-inherited and inherited contributions to metastasis formation.

Authors:  J P Volpe
Journal:  Clin Exp Metastasis       Date:  1992-05       Impact factor: 5.150

2.  Influence of tumor transplantation methods on tumor growth rate and metastatic potential of solitary tumors derived from metastases.

Authors:  J P Volpe; L Milas
Journal:  Clin Exp Metastasis       Date:  1990 Jul-Aug       Impact factor: 5.150

3.  Morphological heterogeneity and phenotypical instability versus metastatic stability in the murine tumor model ER 15-P.

Authors:  G Edel; A Roessner; B Deneke; B Wörmann
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.